24-hr Intraocular Pressure Control With SIMBRINZA ®
NCT02770248
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
162
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension
DRUG:
Vehicle
Sponsor
Alcon Research